TY - JOUR
T1 - The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy
AU - Hanssen, Britta
AU - Peeters, Nicky
AU - Vandekerckhove, Ines
AU - de Beukelaer, Nathalie
AU - Bar-On, Lynn
AU - Molenaers, Guy
AU - van Campenhout, Anja
AU - Degelaen, Marc
AU - van den Broeck, Christine
AU - Calders, Patrick
AU - Desloovere, Kaat
N1 - Funding Information: The authors would like to thank Francesco Cenni and Simon-Henri Schless for the development of the 3DfUS technique, as well as Marije Goudriaan for the development of the custom-designed chair in which isometric strength was assessed. The authors are also very grateful to all the participants who participated in this study and their parents. Funding. BH and NP were funded by a TBM grant (TAMTA-T005416N). This work was further supported by Internal Funds of KU Leuven (C24/18/103), the Flemish Organisation for Scientific Research (3M180752), and the Duchenne Parent Project NL (17.011). IV was funded by a doctoral grant from the Flemish Organisation for Scientific Research (FWO-1188921N) and LB-O from the Dutch Organisation for Scientific Research (NWO-016.186.144). Funding Information: BH and NP were funded by a TBM grant (TAMTA-T005416N). This work was further supported by Internal Funds of KU Leuven (C24/18/103), the Flemish Organisation for Scientific Research (3M180752), and the Duchenne Parent Project NL (17.011). IV was funded by a doctoral grant from the Flemish Organisation for Scientific Research (FWO-1188921N) and LB-O from the Dutch Organisation for Scientific Research (NWO-016.186.144). Publisher Copyright: © Copyright © 2021 Hanssen, Peeters, Vandekerckhove, De Beukelaer, Bar-On, Molenaers, Van Campenhout, Degelaen, Van den Broeck, Calders and Desloovere.
PY - 2021/7/26
Y1 - 2021/7/26
N2 - Muscle weakness is a common clinical symptom in children with spastic cerebral palsy (SCP). It is caused by impaired neural ability and altered intrinsic capacity of the muscles. To define the contribution of decreased muscle size to muscle weakness, two cohorts were recruited in this cross-sectional investigation: 53 children with SCP [median age, 8.2 (IQR, 4.1) years, 19/34 uni/bilateral] and 31 children with a typical development (TD) [median age, 9.7 (IQR, 2.9) years]. Muscle volume (MV) and muscle belly length for m. rectus femoris, semitendinosus, gastrocnemius medialis, and tibialis anterior were defined from three-dimensional freehand ultrasound acquisitions. A fixed dynamometer was used to assess maximal voluntary isometric contractions for knee extension, knee flexion, plantar flexion, and dorsiflexion from which maximal joint torque (MJT) was calculated. Selective motor control (SMC) was assessed on a 5-point scale for the children with SCP. First, the anthropometrics, strength, and muscle size parameters were compared between the cohorts. Significant differences for all muscle size and strength parameters were found (p ≤ 0.003), except for joint torque per MV for the plantar flexors. Secondly, the associations of anthropometrics, muscle size, gross motor function classification system (GMFCS) level, and SMC with MJT were investigated using univariate and stepwise multiple linear regressions. The associations of MJT with growth-related parameters like age, weight, and height appeared strongest in the TD cohort, whereas for the SCP cohort, these associations were accompanied by associations with SMC and GMFCS. The stepwise regression models resulted in ranges of explained variance in MJT from 29.3 to 66.3% in the TD cohort and from 16.8 to 60.1% in the SCP cohort. Finally, the MJT deficit observed in the SCP cohort was further investigated using the TD regression equations to estimate norm MJT based on height and potential MJT based on MV. From the total MJT deficit, 22.6–57.3% could be explained by deficits in MV. This investigation confirmed the disproportional decrease in muscle size and muscle strength around the knee and ankle joint in children with SCP, but also highlighted the large variability in the contribution of muscle size to muscle weakness.
AB - Muscle weakness is a common clinical symptom in children with spastic cerebral palsy (SCP). It is caused by impaired neural ability and altered intrinsic capacity of the muscles. To define the contribution of decreased muscle size to muscle weakness, two cohorts were recruited in this cross-sectional investigation: 53 children with SCP [median age, 8.2 (IQR, 4.1) years, 19/34 uni/bilateral] and 31 children with a typical development (TD) [median age, 9.7 (IQR, 2.9) years]. Muscle volume (MV) and muscle belly length for m. rectus femoris, semitendinosus, gastrocnemius medialis, and tibialis anterior were defined from three-dimensional freehand ultrasound acquisitions. A fixed dynamometer was used to assess maximal voluntary isometric contractions for knee extension, knee flexion, plantar flexion, and dorsiflexion from which maximal joint torque (MJT) was calculated. Selective motor control (SMC) was assessed on a 5-point scale for the children with SCP. First, the anthropometrics, strength, and muscle size parameters were compared between the cohorts. Significant differences for all muscle size and strength parameters were found (p ≤ 0.003), except for joint torque per MV for the plantar flexors. Secondly, the associations of anthropometrics, muscle size, gross motor function classification system (GMFCS) level, and SMC with MJT were investigated using univariate and stepwise multiple linear regressions. The associations of MJT with growth-related parameters like age, weight, and height appeared strongest in the TD cohort, whereas for the SCP cohort, these associations were accompanied by associations with SMC and GMFCS. The stepwise regression models resulted in ranges of explained variance in MJT from 29.3 to 66.3% in the TD cohort and from 16.8 to 60.1% in the SCP cohort. Finally, the MJT deficit observed in the SCP cohort was further investigated using the TD regression equations to estimate norm MJT based on height and potential MJT based on MV. From the total MJT deficit, 22.6–57.3% could be explained by deficits in MV. This investigation confirmed the disproportional decrease in muscle size and muscle strength around the knee and ankle joint in children with SCP, but also highlighted the large variability in the contribution of muscle size to muscle weakness.
KW - cerebral palsy
KW - muscle size
KW - muscle volume
KW - muscle weakness
KW - selective motor control
KW - ultrasound
UR - http://www.scopus.com/inward/record.url?scp=85112210517&partnerID=8YFLogxK
U2 - https://doi.org/10.3389/fneur.2021.692582
DO - https://doi.org/10.3389/fneur.2021.692582
M3 - Article
C2 - 34381414
SN - 1664-2295
VL - 12
JO - Frontiers in neurology
JF - Frontiers in neurology
M1 - 692582
ER -